Saudi market index closes

TASI
10,326.47
+18.10 (+0.18%)
MT30
1,400.46
+2.64 (+0.19%)
NOMU (Capped)
22,054.14
+105.57 (+0.48%)
Sukuk
890.39
-0.62 (-0.07%)

Source: Saudi Exchange data supplied for this session. Not live prices.

GoFinsa

Welcome to GoFinsa!

MOUWASAT

4002

GoFinsa Saudi Stock Investment Strength Index

79%
Investment strength
Explore the GoFinsa Saudi Stocks Index →

Analytical index, not a guaranteed return or buy recommendation.

59.35 SAR
Change: +0.4 SARChange %: +0.68 %Trading volume: 127,330 sharesTrades: 958 Open: 58.95 SARHigh: 59.45 SARLow: 58.45 SAR
Last available trade from session · 2026-11-12

MOUWASAT stock (4002) price and technical analysis

GoFinsa tracks MOUWASAT under symbol 4002, with the latest available price at 59.35 SAR. This page includes multi-timeframe charts, technical analysis and related market news.

Market data source: بيانات جلسة السوق السعودي المقدمة من المستخدم · Latest available update: 2026-11-12 · Delayed market data

Mouwasat Medical Services (4002): Reference Price, GoFinsa Rating and News

GoFinsa’s guide to Mouwasat Medical Services, listed under ticker 4002, outlines its economic sector and factors to consider when researching the stock.

About Mouwasat and Its Business Activities

Mouwasat Medical Services (ticker 4002) operates in the Saudi market and manages healthcare facilities and services. The company description lists hotels, residential real estate, hospitals and healthcare among its business areas. Other areas or products mentioned include medical centers, pharmacies and schools. This overview describes the activities and products listed in that company description; it does not mean that all of them contribute equally to revenue or that they have produced specific financial results.

Mouwasat Stock Information

Mouwasat shares trade on the Saudi Exchange under ticker 4002. The company belongs to the healthcare sector. Following official disclosures and financial results can help readers understand the company’s position and how its operations develop.

Mouwasat’s Activities and Company Information

The company is classified in the healthcare sector of the Saudi market. Refer to its annual reports and official disclosures for information about its activities, revenue sources and operational developments.

The Healthcare Sector in the Saudi Economy

The performance of listed healthcare companies can be affected by demand for their products and services, operating costs, competition, and economic and regulatory conditions. Each company’s exposure to these factors varies according to its business model.

How to Read the Stock’s Financial Results

It is useful to compare revenue, profit, cash flow and debt across multiple financial periods, and to understand the reasons for changes rather than relying on a single quarter’s results. Official announcements should also be reviewed for material events.

Factors That May Affect the Share Price

Mouwasat’s share price may be affected by the company’s results and disclosures, trends in the Saudi market, interest rates and investor expectations. A price movement alone does not indicate improved operating performance.

Investment Risks

Potential risks include share-price volatility, changes in costs, weaker demand, competition and regulatory changes. The actual risks depend on the company’s activities and financial position.

The Stock’s Investment Strength According to the GoFinsa Saudi Stocks Index

The stock’s recorded rating in the GoFinsa GFSI is 81%. This is an independent analytical rating, not a guarantee of profit or a personal recommendation to buy.

Investing in Saudi Stocks

The Saudi Exchange includes companies operating across a range of economic sectors. Investors can benefit from reviewing disclosures, comparing financial assessments, diversifying risk and setting an investment horizon before making a decision.

Following Company News

The latest disclosures and news concerning Mouwasat shares can be followed through news sources and official data available on GoFinsa. Pay attention to the date of each item and whether it relates directly to the company.

Mouwasat’s Reference Share Price

The recorded reference price is 62.0 SAR, dated 2026-10-08. This is a historical price, not a live quote or a confirmed price for current trading.

Mouwasat’s Rating in the GoFinsa GFSI

The stock’s assigned GoFinsa GFSI rating is 81%. This is a GoFinsa research rating, not a recommendation to buy or sell.

Overview of the Healthcare Sector

Mouwasat shares belong to the healthcare sector on the Saudi Exchange. Companies in this sector are affected by demand, competition, costs, and economic and regulatory conditions; their revenue sources and risk profiles differ.

Trading Through XTB and Associated Risks

What Does Mouwasat Do?

Mouwasat (4002) belongs to the healthcare sector. The company’s proposed research scope includes operating hospitals and medical centers and providing treatment services. Verify the precise details and any subsidiaries’ activities against the company’s latest official profile before publication.

Where Does Mouwasat’s Revenue Come From?

When assessing Mouwasat’s business model, review the following potential sources of income where supported by the company’s financial statements: medical-service revenue, visit volumes, occupancy and case mix. Listing these items does not mean that each is an actual contributor to the company’s revenue.

Factors That May Affect Mouwasat’s Performance

Relevant indicators to monitor in connection with Mouwasat’s activities include occupancy rates, expansion, staffing costs and contracts with insurance companies. Compare trends in the company’s actual results across several periods, and do not infer growth or profitability without documented figures.

What to Check in the Annual Disclosure

When researching Mouwasat (4002), first identify the date of the latest annual report. Then review the description of actual activities, operating segments and revenue-recognition policy. Read the notes to the financial statements rather than relying only on management’s summary; the notes may disclose obligations or events that are not apparent from headline figures. Verify the listed entity’s name, its subsidiaries and the nature of their operations before attributing any activity or project to the company. Trends in the healthcare sector alone are not evidence of revenue growth at this company unless supported by its published results.

How to Distinguish Genuine Growth from Accounting Changes

To analyze Mouwasat, compare results for several periods with matching time frames and watch for non-recurring items, reclassifications and changes in the consolidation scope. Higher revenue does not necessarily mean improved profitability if the cost of sales or expenses have increased faster. Review operating and net profit margins, then consult management’s explanations in the notes. Without reliable, up-to-date financial statements, these are analytical steps, not a description of Mouwasat’s actual performance.

Cash Flows and the Ability to Fund Operations

When reviewing Mouwasat’s financial data, distinguish accounting profit from cash generated by operations. Examine net operating cash flow, changes in working capital, capital expenditure and financing costs. A company may report profits while operating cash declines because of increases in receivables, inventory or project payments. Conversely, cash flow may be temporarily affected by the timing of collections and payments. The company’s liquidity or solvency cannot be assessed without the relevant financial statements and notes.

Debt and Financing Costs: Key Questions

If Mouwasat has financing obligations, start by identifying their maturities, the split between short- and long-term debt, borrowing costs and any contractual covenants. Assess how changes in interest rates could affect earnings and cash flow, taking into account whether financing instruments have fixed or variable rates. The relevance of these questions depends on the company’s healthcare business model. This guide does not assume that the company has any particular debt level or risk.

Comparing the Stock with Sector Peers Without Misleading Conclusions

For a fair comparison of Mouwasat, select companies with similar activities, revenue mix, scale and regulatory conditions. Compare revenue growth, margins, return on capital and cash flow, then account for differences in accounting and leverage. A lower price-to-earnings multiple than that of another company is not enough to conclude that the stock is cheaper; the difference may reflect expectations for growth, risk or earnings quality. Where losses or non-recurring profits are involved, some valuation multiples may not be suitable for comparison.

How to Read the Reference Price and Its Date

The reference price in this guide is historical and dated; it is not a live bid or offer. When assessing Mouwasat, check which trading session the price relates to and whether capital changes, a share split or distributions affect historical comparisons. Do not confuse the previous closing price with the latest trade or the session’s average price. If market data updates are delayed, display its date clearly and do not infer a new daily trend from an old figure.

Build Scenarios Instead of Predicting a Specific Price

Mouwasat can be assessed using three scenarios: improved business conditions, continuation of current conditions, and weaker demand or margins. For each scenario, set measurable assumptions such as sales volume, input costs or financing expenses, and compare the outcomes with published financial statements when available. Do not set a price target without a valuation model and documented inputs, or present the positive scenario as an expected outcome. This approach is intended to show how an investment may respond to new information.

Checklist Before Making an Investment Decision

Before dealing in Mouwasat shares, verify the ticker 4002, the company’s identity and the price date, and review the latest material disclosure, financial results and auditor’s notes, if any. Separate GoFinsa’s research rating from whether the investment suits your personal circumstances. Set your investment horizon, assess your tolerance for loss and consider your portfolio’s exposure to the healthcare sector. Review broker fees and the nature of the financial instrument: owning shares directly differs from trading derivatives or contracts for difference, which may carry additional risks.

أسئلة شائعة عن الشركة

What is Mouwasat’s stock ticker?

Its ticker on the Saudi Exchange is 4002.

Which sector does Mouwasat belong to?

The stock belongs to the healthcare sector.

Is the GoFinsa index rating a buy recommendation?

No. The rating is an analytical tool and is not a personal investment recommendation or a guarantee of future performance.

Frequently asked questions about MOUWASAT (4002)

What is the price of MOUWASAT (4002)?

The latest price available in GoFinsa data is 59.35 SAR. Price status may be live or delayed depending on the market and data provider.

What does the technical analysis for MOUWASAT (4002) show?

There is currently insufficient data to produce technical analysis for this instrument.

What is the GoFinsa.com General Index for MOUWASAT?

The GoFinsa.com General Index is currently unavailable for this instrument.